Remarkably, the BRAFm predictor identified 13% of KRAS wt CRC patients with a much poorer prognosis (P = 0.022), capturing a significant number of non-BRAF mutant patients with a BRAFm expression signature. The gene discussed is BRAF; the disease is colorectal carcinoma.